Background At present, extensive hysterectomy and pelvic lymph node dissection are
preferred for early-stage cervical cancer. However, additional adjuvant therapy could be …

The presence of intermediate risk factors reduces the predictability of radical hysterectomy,
demanding the use of adjuvant therapy for treatment of Early stage cervical cancer (ESCC) …

Background The objective of this study is to analyze the treatment outcome and secondary
reactions in 98 patients with stage I–III cervical carcinoma who underwent postoperative …

Objective To compare survival outcomes of different postoperative adjuvant therapies
(PATs) for early‐stage cervical cancer (ECC) patients with one intermediate‐risk …

We conducted a prospective study to assess the non-inferiority of adjuvant chemotherapy
alone versus adjuvant concurrent chemoradiotherapy (CCRT) as an alternative strategy for …

Background: The tumor microenvironment and tumor immunity have become the focus of
research on tumor diagnosis and treatment. Lymphocyte activation gene-3 (LAG-3, CD223) …

Objective To examine the effectiveness of systemic chemotherapy following radical
hysterectomy for women with intermediate-risk stage IB cervical cancer. Materials and …

Objectives There is no consensus on whether giving adjuvant concurrent
chemoradiotherapy (CCRT) is more effective than adjuvant radiotherapy (RT) alone in …

Object: To assess the effects of lymphovascular space invasion (LVSI) on cancer recurrence
and survival in patients with primary epithelial ovarian cancer. Methods: A retrospective …

Purpose The purpose of this study is to compare the prognostic efficacy of the number and
location of positive lymph nodes (LN), LN ratio (LNR), and log odds of positive LNs (LODDs) …